7.03
Bioventus Inc 주식(BVS)의 최신 뉴스
Examining the Future: Bioventus's Earnings Outlook - Nasdaq
Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Legal & General Group Plc Raises Position in Bioventus Inc. (NYSE:BVS) - Defense World
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com
Bioventus Q1 2025 Earnings Preview: Key Metrics and Business Updates Coming May 6 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
LPL Financial LLC Has $433,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Alliancebernstein L.P. Sells 3,500 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
SEC Form DEFA14A filed by Bioventus Inc. - Quantisnow
Bioventus Inc. (NASDAQ:BVS) On The Verge Of Breaking Even - Yahoo Finance
Bioventus SVP Katrina Church sells shares for $9,712 - Investing.com Australia
Bioventus CFO Singleton sells $29,333 in stock - Investing.com Australia
Bioventus SVP Katrina Church sells shares for $9,712 By Investing.com - Investing.com South Africa
Bioventus CFO Singleton sells $29,333 in stock By Investing.com - Investing.com South Africa
Bioventus SVP sells shares worth $22,392 By Investing.com - Investing.com India
Bioventus SVP sells shares worth $22,392 - Investing.com
Bioventus Executives Sell Shares to Cover Taxes - TradingView
Bioventus Inc. (NYSE:BVS) Shares Acquired by Vanguard Group Inc. - Defense World
KLP Kapitalforvaltning AS Acquires Shares of 7,100 Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus ($BVS) Is Paying a $15.2M Settlement to Investors — Here’s How to Get Your Share - TradingView
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
Commonwealth Equity Services LLC Raises Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus Inc.'s (NASDAQ:BVS) institutional investors lost 9.6% over the past week but have profited from longer-term gains - simplywall.st
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
HighTower Advisors LLC Increases Position in Bioventus Inc. (NYSE:BVS) - Defense World
(BVS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Ensign Group Invests in Growth With New Facility Acquisitions - TradingView
Canaccord maintains Bioventus stock with $15 target, bullish outlook By Investing.com - Investing.com Australia
Canaccord maintains Bioventus stock with $15 target, bullish outlook - Investing.com
Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Bone Growth Stimulator Market Is Booming Worldwide | Orthofix Medical Inc., Medtronic, Zimmer Biomet, Bioventus Inc - openPR.com
Charles Schwab Investment Management Inc. Grows Position in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus CFO Mark Leonard sells $53,639 in stock By Investing.com - Investing.com Australia
Bioventus CFO Mark Leonard sells $53,639 in stock - Investing.com India
(BVS) Proactive Strategies - news.stocktradersdaily.com
Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates - MSN
Bioventus SVP Katrina Church sells shares worth $9,925 By Investing.com - Investing.com Australia
Bioventus SVP Anthony D’Adamio sells $25,496 in stock - Investing.com India
Bioventus SVP Katrina Church sells shares worth $9,925 - Investing.com India
Europe Viscosupplementation Market Projected To Witness Substantial Growth, 2025-2032: Sanofi S.A., Bioventus - EIN News
Bioventus (NYSE:BVS) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Bioventus (BVS) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
How To Trade (BVS) - news.stocktradersdaily.com
Earnings call transcript: Bioventus Q4 2024 beats revenue forecast, stock surges - Investing.com Australia
Bioventus Earnings Call: Strong Growth & 2025 Outlook - TipRanks
Bioventus Inc. (NASDAQ:BVS) Q4 2024 Earnings Call Transcript - Insider Monkey
Bioventus: Strong Financial Performance and Strategic Growth Drive Buy Rating - TipRanks
Bioventus Full Year 2024 Earnings: Beats Expectations - Yahoo
Bioventus Faces Potential Stock Dilution Risk Amid Resale of 35 Million Shares - TipRanks
Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ... - Yahoo Finance
자본화:
|
볼륨(24시간):